Abdel Samie Ahmed, Theilmann Lorenz
Department of Gastroenterology, Pforzheim Hospital, Kanzlerstr. 2-6, 75175, Pforzheim, Germany.
Eur J Trauma Emerg Surg. 2013 Apr;39(2):191-4. doi: 10.1007/s00068-013-0250-1. Epub 2013 Jan 30.
Intramural intestinal hematoma is considered a rare complication of overanticoagulation in elderly patients. Nevertheless, this clinical entity is increasingly being reported in the literature, and its incidence is predicted to increase further as a result of the wide use of long-term anticoagulation in an aging population. However, data regarding the risk factors and optimal management of this unusual complication in patients on phenprocoumon/warfarin are scarce.
We retrospectively analyzed the medical reports of patients with intramural gastrointestinal hematoma on anticoagulant therapy who were treated in our unit between January 2008 and July 2011.
Four consecutive patients were identified during the study period. The mean age of the patients was 80 years. All patients were on uninterrupted anticoagulation with phenprocoumon due to chronic atrial fibrillation. Hematoma was localized in the duodenum in one patient, in the jejunum in two patients, and in the rectum in one patient. Hematoma occurred spontaneously in three patients and following a trauma in one patient. Excessive anticoagulation with an INR of >6 was associated with the development of this complication in all spontaneous cases. A combination of computed tomography and sonography established the diagnosis in all four. Conservative therapy proved successful in two patients, and surgery was necessary in two cases.
Intramural hematoma of the gastrointestinal tract should be suspected in any patient with abdominal pain or intestinal obstruction under anticoagulant therapy. Emergency physicians and surgeons should be aware of this rare complication, as most such cases will resolve spontaneously under conservative measures without the need for surgery.
肠壁内肠血肿被认为是老年患者过度抗凝治疗的一种罕见并发症。然而,这一临床实体在文献中报道得越来越多,并且由于在老龄化人群中广泛使用长期抗凝治疗,其发病率预计还会进一步上升。然而,关于接受苯丙香豆素/华法林治疗的患者发生这种不寻常并发症的危险因素和最佳治疗方法的数据却很匮乏。
我们回顾性分析了2008年1月至2011年7月在我们科室接受抗凝治疗的肠壁内胃肠道血肿患者的病历报告。
在研究期间共确定了4例连续患者。患者的平均年龄为80岁。所有患者因慢性房颤均在持续接受苯丙香豆素抗凝治疗。1例患者血肿位于十二指肠,2例位于空肠,1例位于直肠。3例患者血肿为自发性发生,1例继发于外伤。在所有自发性病例中,国际标准化比值(INR)>6的过度抗凝与该并发症的发生有关。计算机断层扫描和超声检查相结合确诊了所有4例患者。保守治疗在2例患者中取得成功,2例患者需要手术治疗。
对于任何接受抗凝治疗且出现腹痛或肠梗阻的患者,均应怀疑有胃肠道壁内血肿。急诊医生和外科医生应了解这种罕见并发症,因为大多数此类病例在保守治疗措施下可自行缓解,无需手术。